IgA Nephropathy (also known as Berger's disease) is a progressive autoimmune disease that results in chronic inflammation of the kidneys and leads to reduced kidney function over time. The kidneys’ primary function is to filter the blood to remove waste and excess fluid. IgA nephropathy damages the kidneys’ ability to function properly. IgA nephropathy is a progressive disease, with up to 50% of IgA nephropathy patients developing end-stage kidney disease within 20 years, requiring dialysis or kidney transplant for survival.

• Are 18-65 years old
• Have been diagnosed with IgAN following a kidney biopsy
• Are currently being treated with an angiotensin receptor blocker (ARB) or ACE inhibitor
• Are NOT currently being treated with corticosteroid tablets or immune-suppressing treatments
• Have ongoing proteinuria (high levels of protein in urine)

Qualified participants will  receive:

• Study medication and study-related medical care at no cost
• Compensation for travel and other expenses

Health Insurance is not required to participate.

Call 416--844-2990 or complete the short form.